Clifford R. Jack Jr.

Physiology · 2000–2024

A researcher in the Science corpus: 44 papers; trusts 21 researchers and is trusted by 17 researchers here, as inferred from the citation graph.

Subfields

• Physiology — 520 citations into it; #163 of 2,276 by trust here, #14 by citations
• Psychiatry and Mental health — 482 citations into it; #88 of 1,338 by trust here, #1 by citations
• Neurology — 219 citations into it; #808 of 1,455 by trust here, #127 by citations
• Cognitive Neuroscience — 200 citations into it
• Molecular Biology — 148 citations into it; #10,442 of 17,773 by trust here, #6,410 by citations
• Radiology, Nuclear Medicine and Imaging — 142 citations into it
• Cellular and Molecular Neuroscience — 69 citations into it
• Computer Vision and Pattern Recognition — 36 citations into it

Whom Clifford R. Jack Jr. trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. D. Selkoe
2. H. Braak
3. William E. Klunk
4. Julie A. Schneider
5. Bruno Dubois
6. Mark A. Mintun
7. Kaj Blennow
8. Anne M. Fagan
9. Ronald C. Petersen
10. Zoe Arvanitakis

Who trusts Clifford R. Jack Jr. overall

1. J. Long
2. D. Holtzman
3. S. Budday
4. Reisa A. Sperling
5. Bruno Dubois
6. Jiayu Zhou
7. David S. Knopman
8. Esther E. Bron
9. A. Maass
10. Ronald C. Petersen

Papers from Clifford R. Jack Jr.'s perspective

Ordered by how strongly the researchers Clifford R. Jack Jr. trusts endorse each paper. Same corpus, a different order for every researcher.

1. Neuropathological stageing of Alzheimer-related changes
2. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B (Annals of Neurology)
3. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory (Journal of Neuroscience)
4. Current concepts in mild cognitive impairment. (Archives of Neurology)
5. Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B (Journal of Cerebral Blood Flow and Metabolism)
6. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia (Proceedings of the National Academy of Sciences of the United States of America)
7. The pathological process underlying Alzheimer’s disease in individuals under thirty (Acta Neuropathologica)
8. PET imaging of amyloid deposition in patients with mild cognitive impairment. (Neurobiology of Aging)
9. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. (Archives of Neurology)
10. Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly (Archives of Neurology)

Their papers

• Common genetic variants influence human subcortical brain structures (2015) — 868 citations
• Biomarker Modeling of Alzheimer's Disease (2013) — 976 citations
• Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort (2010) — 393 citations
• Introduction to Revised Criteria for the Diagnosis of Alzheimer’s Disease: National Institute on Aging and the Alzheimer Association Workgroups (2011) — 1,981 citations
• Magnetic resonance elastography of the brain (2008) — 421 citations
• The genetic architecture of the human cerebral cortex (2020) — 777 citations
• Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup (2024) — 2,186 citations
• Brain charts for the human lifespan (2021) — 1,503 citations
• Four distinct trajectories of tau deposition identified in Alzheimer’s disease (2021) — 636 citations
• Changing the face of neuroimaging research: Comparing a new MRI de-facing technique with popular alternatives (2021)
• Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report (2019) — 1,263 citations
• Quantitative magnetic resonance imaging phantoms: A review and the need for a system phantom (2018) — 149 citations
• NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease (2018) — 3,155 citations
• Defining imaging biomarker cut points for brain aging and Alzheimer's disease (2017) — 842 citations
• Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria (2016) — 1,741 citations
• Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) — 1,062 citations
• A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers (2016) — 1,607 citations
• The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data (2014) — 790 citations
• An Operational Approach to NIA-AA Criteria for Preclinical Alzheimer’s Disease (2012) — 607 citations
• The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease (2011) — 16,320 citations